Episode 4: Are peptides legal in the U.S. After FDA Category 2?
February 14, 2026 · 11:13
FDA's Category 2 and 503A rules bar many peptides (e.g., BPC-157) from legal pharmacy compounding.
Peptide therapy
Explore the use of therapeutic peptides such as BPC-157, CJC-1295, and others for recovery, hormone optimization, and overall performance. Learn how peptide therapy can support men's health goals including muscle growth, fat loss, and longevity.
Most-read topics as podcast episodes
We only record episodes on the topics readers care about most.
Start here
The essentials for peptide therapy — then explore the latest posts below.
BPC-157 FDA status in 2026: Compounding and legality
Dr. Susan Carter, MD: Endocrinologist & Longevity Expert
Dec 03, 2025 · 13 min read
As of 2026, BPC-157, CJC-1295, and ipamorelin are not FDA-approved drugs, and all appear on the FDA’s Section 503A “Category 2” list (FDA Category 2 list, accessed February 15, 2026). Thymosin beta-4, which is often marketed online under the nickname “TB-500,” also appears on the FDA’s Section 503A “Category 2” list (FDA Category 2 list, ...